Private Wegovy vs Mounjaro: Compare Your Options
Private Prescription Pathway: Wegovy Equivalent to Mounjaro 7.5mg Access
The private prescription route for Wegovy equivalent to Mounjaro 7.5mg eliminates the complex NHS referral system that requires GP consultation, specialist weight management service referral, and often 6+ month waiting periods. EverydayMeds' streamlined approach allows eligible patients to complete a 3-minute clinical assessment online, receive prescriber review within 24-72 hours, and access the same genuine prescription-only medicine available through NHS channels. Our GPhC-registered pharmacy (#9012878) maintains identical clinical standards whilst offering significantly faster access to both treatment options.
Private prescribing also provides flexibility in choosing between Wegovy and Mounjaro based on individual preferences rather than formulary restrictions. Patients seeking Wegovy equivalent to Mounjaro 7.5mg comparison can discuss both options with our prescribers, who evaluate medical history, current medications, and lifestyle factors to recommend the most suitable treatment. The private pathway ensures continuity of supply without the disruptions often experienced in NHS weight management services due to capacity constraints and funding limitations.
Wegovy vs Mounjaro 7.5mg: Transparent Pricing Structure
Understanding the cost of Wegovy equivalent to Mounjaro 7.5mg through private prescription requires transparent pricing comparison. Wegovy follows a mandatory dose escalation schedule: 0.25mg starter dose costs £79.99, progressing through 0.5mg (£94.99), 1mg (£99.99), 1.7mg (£139.99), to the 2.4mg maintenance dose (£209.99). Our bundle options provide supply continuity, such as the Intro Trio containing 0.25mg, 0.5mg, and 1mg doses for £299.99, covering the initial 12-week titration period. New customers apply discount code FIRST40 at checkout, whilst returning customers use DOSE25 to reach these final prices.
Mounjaro pricing differs due to its tirzepatide formulation and dosing schedule, though both treatments require similar long-term financial commitment for sustained weight management. The Wegovy equivalent to Mounjaro 7.5mg cost comparison should factor in storage advantages, with Wegovy maintaining stability for 6 weeks at room temperature versus Mounjaro's 21-day limit. This storage flexibility can reduce waste and improve treatment adherence, particularly for patients with variable schedules or frequent travel requirements that characterise many private prescription patients.
Clinical Evidence: Wegovy Equivalent to Mounjaro 7.5mg Efficacy
The STEP trial programme demonstrates that patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks in STEP 1, with STEP 5 showing sustained clinically studied weight loss at 2 years (Wilding et al., NEJM, 2021). These results position Wegovy as a clinically validated option when comparing Wegovy equivalent to Mounjaro 7.5mg effectiveness. The SELECT cardiovascular outcomes trial further showed 20% reduction in major cardiovascular events, highlighting benefits beyond weight management for eligible patients.
Direct head-to-head trials between semaglutide and tirzepatide utilise different study designs, populations, and endpoints, making percentage comparisons inappropriate without clinical context. Both Wegovy and Mounjaro are available from EverydayMeds, and your prescriber can help determine which treatment aligns with your medical profile, preferences, and weight management goals based on individual assessment rather than population-level trial data.
Wegovy Mechanism: GLP-1 Receptor Agonist Action
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics the natural incretin hormone GLP-1 produced in your intestines after eating. This prescription-only medicine works by binding to GLP-1 receptors in the brain's appetite control centres, reducing hunger signals and promoting feelings of fullness after smaller meals. Unlike Mounjaro's dual GIP and GLP-1 receptor action, Wegovy focuses specifically on GLP-1 pathways to support weight management. The medication may also slow gastric emptying, helping patients feel satisfied for longer periods between meals. When comparing Wegovy equivalent to Mounjaro 7.5mg mechanisms, the single-receptor approach offers well-established clinical experience with predictable dose-response relationships throughout the escalation schedule.
Streamlined Ordering Process for Private Wegovy Prescriptions
Accessing Wegovy equivalent to Mounjaro 7.5mg through EverydayMeds begins with our 3-minute online clinical assessment covering medical history, current medications, weight management goals, and contraindication screening. Our qualified prescribers review applications within standard 3 working days, with express 24-hour review available for urgent requirements. Once approved, your prescription-only medicine ships via next-day cold-chain delivery maintaining the required 2-8°C temperature throughout transit to ensure medication stability and efficacy. The entire process eliminates traditional pharmacy visits, GP appointments, and specialist referral delays that characterise NHS pathways. Our GPhC-registered service (#9012878) maintains full clinical governance whilst providing the convenience and speed that private patients expect.
Storage and Practical Considerations: Wegovy vs Mounjaro 7.5mg
Wegovy's storage profile offers practical advantages when comparing Wegovy equivalent to Mounjaro 7.5mg options for active lifestyles. The FlexTouch pre-filled pen must be stored in the fridge at 2-8°C before first use, but once removed, maintains stability for up to 6 weeks at room temperature below 30°C. This extended room temperature stability exceeds Mounjaro's 21-day limit, providing greater flexibility for business travel, holidays, or irregular schedules common among private prescription patients. The mandatory dose escalation schedule requires 4 weeks at each dose level, allowing your body to adapt gradually whilst minimising potential side effects. Each pen delivers exactly 4 weekly doses through the simple click-mechanism, with clear dose indicators ensuring accurate administration throughout your treatment journey.
Private vs NHS Access: Why Choose Private Wegovy Equivalent to Mounjaro 7.5mg
NHS access to Wegovy requires meeting strict BMI criteria, completing tier 3 weight management programmes, and demonstrating failure with previous interventions before specialist referral consideration. NICE TA875 recommends Wegovy within specialist weight management services, but capacity limitations mean waiting times often exceed 6 months in many CCG areas. Private prescription bypasses these restrictions, offering immediate assessment for clinically appropriate candidates without the bureaucratic delays that frustrate many patients seeking timely weight management intervention.
The private route for Wegovy equivalent to Mounjaro 7.5mg also provides treatment continuity assurance, avoiding the supply disruptions and formulary changes that can interrupt NHS prescribing. EverydayMeds maintains consistent stock levels of all Wegovy doses, ensuring seamless progression through the escalation schedule without treatment gaps that could compromise your weight management progress and require restarting from lower doses.
Complete Your Wegovy Assessment Today
Ready to compare Wegovy equivalent to Mounjaro 7.5mg through private prescription? Our clinical assessment takes just 3 minutes and covers everything our prescribers need to evaluate your suitability for treatment. New customers apply discount code FIRST40 at checkout, whilst returning customers use DOSE25 to access our competitive pricing from £79.99 for the starter dose. Visit https://everydaymeds.co.uk/collections/wegovy to begin your assessment and take the first step towards clinically supervised weight management. Our experienced prescribers provide personalised recommendations based on your individual medical profile, ensuring you receive the most appropriate treatment for your weight management goals. Remember that both Wegovy and Mounjaro must be used alongside a reduced-calorie diet and increased physical activity for optimal results.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
